Home › Sjogren's Syndrome › Michigan
Sjogren's Syndrome clinical trials in Michigan
3 studies for Sjogren's Syndrome are looking for participants at sites in Michigan.
Cities in Michigan
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Clinical Research Inst of MI, Saint Clair Shores
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07621809Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Clinical Research Institute of Michigan, LLC, Saint Clair Shores
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 27, 2026 · NCT07404865A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- Shores Rheumatology, Saint Clair Shores
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06747949From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.